Europe - Frankfurt Stock Exchange - FRA:2HRA - DE000A2E4T77 - Common Stock
The current stock price of 2HRA.DE is 4.41 EUR. In the past month the price decreased by -7.16%. In the past year, price increased by 31.64%.
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| 1COV.DE | COVESTRO AG | N/A | 11.34B | ||
| AKZA.AS | AKZO NOBEL N.V. | 16.07 | 10.00B | ||
| AKU1.DE | AKZO NOBEL N.V. | 16.02 | 9.97B | ||
| SY1.DE | SYMRISE AG | 18.84 | 9.56B | ||
| SYENS.BR | SYENSQO SA | 20.89 | 7.05B | ||
| EVK.DE | EVONIK INDUSTRIES AG | 9.64 | 6.11B | ||
| UMI.BR | UMICORE | 15.81 | 4.40B | ||
| NVJP.DE | UMICORE | 15.81 | 4.40B | ||
| AKE.PA | ARKEMA | 9.9 | 3.88B | ||
| WCH.DE | WACKER CHEMIE AG | 154.88 | 3.47B | ||
| RBT.PA | ROBERTET SA | 18.59 | 1.89B | ||
| ACT.DE | ALZCHEM GROUP AG | 23.8 | 1.48B |
H&R GmbH & Co. KGaA is a holding company, which engages in the manufacture of mineral oil specialties. The company is headquartered in Salzbergen, Niedersachsen and currently employs 1,719 full-time employees. The Company’s two business activities are chemicals and pharmaceutical raw materials and precision plastic parts. The company operates through three segments: ChemPharm Refining, ChemPharm Sales and Plastics. The ChemPharm Refining segment, which produces oils, technical and medical white oils as well as paraffins and wax products; the ChemPharm Sales segment, which produces plasticizers and wax emulsions and the Plastics segment manufacturing precision plastic parts as well as assemblies and medical consumables.
H&R GMBH & CO KGAA
Neuenkirchener Str. 8
Salzbergen NIEDERSACHSEN DE
Employees: 1719
Phone: 4959769450
H&R GmbH & Co. KGaA is a holding company, which engages in the manufacture of mineral oil specialties. The company is headquartered in Salzbergen, Niedersachsen and currently employs 1,719 full-time employees. The Company’s two business activities are chemicals and pharmaceutical raw materials and precision plastic parts. The company operates through three segments: ChemPharm Refining, ChemPharm Sales and Plastics. The ChemPharm Refining segment, which produces oils, technical and medical white oils as well as paraffins and wax products; the ChemPharm Sales segment, which produces plasticizers and wax emulsions and the Plastics segment manufacturing precision plastic parts as well as assemblies and medical consumables.
The current stock price of 2HRA.DE is 4.41 EUR. The price decreased by -1.12% in the last trading session.
H&R GMBH & CO KGAA (2HRA.DE) has a dividend yield of 2.22%. The yearly dividend amount is currently 0.1.
2HRA.DE has a ChartMill Technical rating of 2 out of 10 and a ChartMill Fundamental rating of 3 out of 10.
The Revenue of H&R GMBH & CO KGAA (2HRA.DE) is expected to decline by -4.97% in the next year. Check the estimates tab for more information on the EPS, Sales, EBIT and EBITDA future analyst estimates.
H&R GMBH & CO KGAA (2HRA.DE) has a market capitalization of 164.14M EUR. This makes 2HRA.DE a Micro Cap stock.
H&R GMBH & CO KGAA (2HRA.DE) will report earnings on 2026-04-07.
ChartMill assigns a technical rating of 2 / 10 to 2HRA.DE. When comparing the yearly performance of all stocks, 2HRA.DE is one of the better performing stocks in the market, outperforming 72.29% of all stocks.
ChartMill assigns a fundamental rating of 3 / 10 to 2HRA.DE. There are concerns on the financial health of 2HRA.DE while its profitability can be described as average.
Over the last trailing twelve months 2HRA.DE reported a non-GAAP Earnings per Share(EPS) of 0.1. The EPS decreased by -30.03% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 0.31% | ||
| ROA | 0.4% | ||
| ROE | 0.95% | ||
| Debt/Equity | 0.13 |
For the next year, analysts expect an EPS growth of -64.54% and a revenue growth -4.97% for 2HRA.DE